Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles
Update: 2025-12-01
1
Description
While lipid nanoparticles are the most clinically advanced drug delivery system for nucleic acid therapeutics, they are only one tool in a toolbox of potential delivery vehicles.
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:
To learn more about the PODD Conference, please visit Drug-Delivery.org.
In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss additional tools, including polymeric nanoparticles, protein-based nanoparticles and extracellular vesicles with a focus on:
- Where LNPs potentially fall short
- Where different tools can enable therapeutic delivery
- Challenges to achieving meaningful clinical impact for these different vehicles
- Building out a portfolio of delivery vehicles
To learn more about the PODD Conference, please visit Drug-Delivery.org.
Comments
In Channel


















